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EDITOR IAL 
Immunology of the Epidermis: Changing Perspectives 
Unt il relatively recent ly t he skin was considered solely a 
t arget for immune-mediated damage rather t han a possible site 
for the init iation of immunologic events. The main interest 
immunologists had in skin was based on elicitation and meas-
urement of delayed-type hypersensit ivity reactions. This con -
cept of a passive role of the skin in immune-mediated reactions 
h as been changing. In 1971, Silberberg suggested that epidermal 
Langerhans cells (LC) play a role in contact hypersensit ivity 
[1], alt hough proof of the involvement of LC in immune func-
t ion did not come unt il 1978 with the studies of Sting! et a! [2] 
who demonstrated that LC could stimulate allogeneic T cells. 
· Since t hat t ime, the function of LC, in part icular t heir role in 
T -cell activation , has been the subject of intensive investiga-
tion . 
Recent studies have focused on t he importance of hormone-
like soluble helper factors in the generation ofT -cell reactivity. 
E vidence indicates that stimulation of ant igen -specific T -cell 
proliferation by certain cell types requires the delivery of two 
signals: presentation of ant igen in conjunction with HLA-DR 
or ! -region products (signal 1) and the production of ant igen 
nonspecific amplificat ion factors (signal 2). Inte rleukin 1 (IL 
1), previously termed lymphocyte activating factor (LAF) (3], 
is t hought to provide t his nonspec ific amplification. Recent ly 
it has been shown that leukocytic pyrogen, t he molecule re-
sponsible for endogenous fever in mammals, is similar if not 
ident ical to IL 1 [4). 
S ince LC play an obligate role in epidermal cell-driven ant i-
gen -specific and allogeneic T -cell activation, studies were un -
dertaken to investigate whether LC, like macrophages, produce 
IL 1. These studies revealed the somewhat unexpected finding 
that ep idermal cells devoid of LC produce a facto r similar to 
IL 1. Since this factor was produced by cells unrelated to cells 
of monocyte/macrophage lineage, it was termed ep idermal thy-
mocyte-activating facto r (ETAF) [5]. In pa rallel studies it was 
found t hat ET AF was produced by the spontaneously trans-
formed keratinocyte cell line P AM 212 (6]. In more recent 
studies ut ilizing epidermal cells enriched for LC it is clear that 
LC can also produce a factor wi th IL 1-like activity. (DN 
Sauder, VB Morhenn, CA Dinarello unpublished data). In t his 
issue of the J ournal, Luger et al study ETAF derived from 
normal human epidermal cells and the squamous cell carcinoma 
cell line SCC15 [7]. They have part ially characterized human 
ETAF as a protein of approximately 15,000 dalton which eluted 
from chromatofocusing at isoelectric poin ts of 7.2, 5.8, and 5.0. 
In addi t ion, t hey have shown that human ETAF is capable of 
inducing serum amyloid A in mice, is mitogenic for human 
dermal fibroblasts, and is chemotactic fo r rabbit polymorpho-
nuclear leukocytes. 
In similar lines of investigation it has been shown that human 
ETAF derived from t he epidermoid carcinoma cell line A431 
has chemotactic activity for human polymorphonuclear leuko-
cytes, and like leukocytic pyrogen, ETAF has the ability to 
induce fever [8). Furthermore, it has been shown that this 
chemotactic activity, fever-inducing activity, and thymocyte-
activating activity can all be blocked by an ant ibody raised 
against leukocytic pyrogen [9]. These studies give further sup-
port to t he concept that t he epidermal cell products may play 
an important role in immunologic reactions. P reliminary stud-
ies from our laboratory suggest t hat interventio ns that increase 
epidermal cell proli fe ration also increase ETAF. Studies are 
current ly under way to determine whether ETAF is increased 
in disease states characteri zed by increased epidermal cell 
proli feratio n such as psoriasis. If ET AF is indeed increased in 
psoriasis, increased amounts of ETAF may then cont ribute to 
the chemotactic activity previously fou nd within psor iatic epi -
dermis [10- 12]. 
In addit ion to those studies indicating the importance of LC 
and soluble facto rs in immunologic reactions, t here are some 
int riguing observations which suggest t hat the role of epidermal 
cells in immunity may not be restricted to t he skin . T here is a 
strong anatomical association between skin epit helium and t he 
thymus. Van Gawdecker and Schmale [13] demonstrated that 
the core of Hassall 's corpuscles is composed of keratin , and 
Sun , Shih , and Green [14] demonstrated t hat keratinocytes 
and epithelial cells of Hassall 's corpuscles express cross-reac-
t ive ant igens. Streilein has proposed that t here is a migration 
of lymphocytes from blood to skin and back, t he so-called skin-
associated lymphoid t issue or SALT [15). He has postulated 
t hat t he skin may provide an inductive microenvironment 
reminiscent of t he thymus, t hrough which precursor lympho-
cytes t raffic and become committed to a particularly unique 
line of di fferent iation [15], possibly with specific skin -directed 
migration [16]. 
Support for t he possible role of skin in T -cell different iation 
is given by t he study of Rubenfeld et a l [17], who demonstrated 
t hat epidermal cell cult ure supernatant was able to induce both 
undi fferent iated murine bone marrow cells and human T cells 
to express the early T -cell different iation marker, terminal 
deoxynucleotidyl t ransferase. In other studies, Kato et al (18] 
showed by indirect immunofluorescence that epidermal cells 
bind an ant ibody against serum thymic factor (FTS) . 
In this issue of the J ournal, Chu et al report experiments 
examining t he relationship between thymus and human skin 
by using an ant iserum to thymopoietin, a thymic hormone 
distinct from FT S [19]. These investigators found that 8- 14% 
of fres hly prepa red human epidermal cells stained with a het-
erologous ant ibody to t hymopoietin; 2- 5% of human epidermal 
cells maintained in short-term tissue cul ture showed cyto-
plasmic staining wit h this ant ithymopoietin ant ibody. By em-
ploying a double- labeling immunofluorescence tec hnique they 
demonstrated that t hese t hymopoietin-staining cells did not 
react wit h the monoclonal antibody OKT6 (which reacts with 
immature thymocytes and epidermal LC). It was also shown 
that in frozen sections of normal human skin ant ithymopoietin 
stains in the basal layer keratinocytes, giving further support 
to t he relationship between sk in and thymus. 
In other studies suggesting a relationship between skin and 
thymus, Chambers et al (20,21 ) and independent ly Bergstresser 
eta! [22] and T schachler et al [23] have recent ly reported that 
the T -cell ant igen T hy-1 is found on a subpopulation of murine 
epidermal cells. These T hy-1-posit ive cells are dendri t ic cells, 
distinct from ep idermal LC. T he biologic role of these T hy-1, 
FTS, or thymopoietin -like staining cells is current ly under 
investigation. In addition , Haynes et a l have reported that 
human epidermal cells in cul ture induced expression of the 
ant igen recognized by OKT6 in a population of neoplastic 
helper T cells [24). Although t he significance of the above 
findings is not clear, it is likely that further study of T cell-
epidermal cell interactions will help in t he understanding of 
certain pathologic condit ions such as cutaneous T -cell lym-
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phoma, in which the malignant cells have been shown both 
phenotypically [25,26] and functiona lly [27] to represent helper 
T cells. 
These studies, together with the two reports in this issue of 
the J ournal, suggest that in addit ion to the recognized antigen-
present ing functions of LC, t he epidermis has potentially im-
portant functions in the immune system and may play a role 
in normal and immunopathologic states. It remains to be de-
termined whether or not epidermal factors play a role in normal 
homeostasis, and what regulates their function . It is possible 
that molecules such as ETAF, FTS, or thymopoietin-like epi-
dermal factors could influence lymphocytes and inf1ammatory 
cells to develop skin specificity . Alteration of the amount or 
function of such factors may be important in the pathogenesis 
of inf1ammatory or neoplastic diseases affecting the skin . 
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